KR-27452

CAT: 0804-HY-179469Size: 1 EachDry Ice: NoHazardous: No
CAT#:0804-HY-179469Size:1 Each
Selected
PRICE
AVAILABILITY: InStock
24/48H Stock Items & 2 to 6 Weeks non Stock Items.
Product image 1
1 / 1
Description
KR-27452 is a selective and orally active PI4KIIIβ inhibitor with an IC50 of 0.026 μM, while showing no activity against PI4KIIIα (IC50 >10 μM) . KR-27452 specifically binds to and inhibits PI4KIIIβ, leading to reduced viral replication in cells. KR-27452 exhibits strong antiviral activity against human rhinovirus (RVs) and Coxsackievirus (COXs) . KR-27452 can be used for the research of infection[1].
UNSPSC
12352005
Target
Enterovirus; PI4K
Related Pathways
Anti-infection; PI3K/Akt/mTOR
Applications
COVID-19-anti-virus
Field of Research
Infection
Smiles
O=C(N(CCCO)C)C1=CC(C2=C(C)N=C(NC(CC3=CC=CC=C3)=O)S2)=CC=C1OC
Molecular Formula
C24H27N3O4S
Molecular Weight
453.55
References & Citations
[1]Ayele SA, et al. 2-amido-3-aryl-4-methyl-thiazole derivatives as broad-spectrum anti-rhinoviral agents. Eur J Med Chem. 2026;302 (Pt 3) :118318.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
PI4KIIIβ

Related Products

CatalogName
HY-156399KR-27425
HY-169300KR-40795
HY-124158KR-60436
HY-118778-01KR-32568
HY-118683KR-31378
HY-136111KR-26556
HY-167853KR-31080
HY-143248-01KR-39038
HY-161357KR-27370
HY-19216KR-30450

Alternative Products

CatalogName
M10102-01KR-33494
T81973-01KR-27425
T64266-01KR-39038
T36569-01KR-32568
TQ0220-01KR-33493
T69802-01KR 60436
T27738-01KR-30450
MBS5777443KR-31378
T70763-01KR-67607
T209484-01KR-27370

Popular Products